Glycogen synthase kinase-3 beta (GSK-3 beta) blockade with 9-ing-41 in gastrointestinal cancers: The 1801 phase Ib/II study-MedSci.cn

Glycogen synthase kinase-3 beta (GSK-3 beta) blockade with 9-ing-41 in gastrointestinal cancers: The 1801 phase Ib/II study

Safran, H; Dhawan, MS; Cavalcante, L; De Souza, AL; Powell, SF; Billadeau, DD; Giles, FJ; Munster, PN; Carneiro, BA

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):

科室
- - 订阅+
  - 更多科室
工具
服务